Exactly. Some shareholder seemed to want The NY Times reporting on Estrada as the plunger on the syringe was pushed. Let him get out of the woods, let the company leverage this development with the Philippines’ government and regulatory agencies.

The news Friday that LL saved Estrada is legit and perhaps the catalyst we need to light a fire under LL globally.

But too many are expecting too much, too soon.

Could NP legally PR it tomorrow? Perhaps.
Should he? Maybe not yet. If the family or local FDA don’t want to tout it yet, NP would be wise to play ball for the time being. Just focus on more patients and more successes.